|
WO1997038688A1
(en)
*
|
1996-04-12 |
1997-10-23 |
Peptide Technology Pty. Limited |
Methods of treating immunopathologies using polyunsaturated fattyacids
|
|
US6576636B2
(en)
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
US5760083A
(en)
*
|
1996-08-07 |
1998-06-02 |
Wisconsin Alumni Research Foundation |
Use of CLA to reduce the incidence of valgus and varus leg deforomities in poultry
|
|
US5804210A
(en)
*
|
1996-08-07 |
1998-09-08 |
Wisconsin Alumni Research Foundation |
Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein
|
|
GB9622636D0
(en)
*
|
1996-10-30 |
1997-01-08 |
Scotia Holdings Plc |
Presentation of bioactives
|
|
CZ326896A3
(cs)
*
|
1996-11-07 |
1998-05-13 |
Milo Olomouc, A. S. |
Tuk se specifickými protisklerotickými účinky
|
|
GB9705102D0
(en)
*
|
1997-03-12 |
1997-04-30 |
Scotia Holdings Inc |
Presentation of fatty acids
|
|
WO1998048788A1
(en)
*
|
1997-04-29 |
1998-11-05 |
Scotia Holdings Plc |
Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
|
|
DE19718245C5
(de)
*
|
1997-04-30 |
2004-11-11 |
Cognis Deutschland Gmbh & Co. Kg |
Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung
|
|
GB9715444D0
(en)
*
|
1997-07-22 |
1997-09-24 |
Scotia Holdings Plc |
Therapeutic and dietary compositions
|
|
US6019990A
(en)
*
|
1997-11-21 |
2000-02-01 |
Natural Nutrition Ltd. As |
Conjugated linoleic acid delivery system in cosmetic preparations
|
|
US6136985A
(en)
*
|
1997-12-23 |
2000-10-24 |
Dcv, Inc. |
CLA esters and uses thereof
|
|
JPH11209279A
(ja)
*
|
1998-01-05 |
1999-08-03 |
Natural Ltd As |
体重減少および肥満処置の方法
|
|
US20020002154A1
(en)
*
|
1998-02-11 |
2002-01-03 |
Pol-Henri Guivarc'h |
Method and composition for treatment of inflammatory conditions
|
|
AU762246B2
(en)
*
|
1998-02-11 |
2003-06-19 |
Rtp Pharma Corporation |
Method and composition for treatment of inflammatory conditions
|
|
GB9804361D0
(en)
*
|
1998-03-02 |
1998-04-22 |
Scotia Holdings Plc |
Cancer treatment
|
|
US7029691B1
(en)
|
1998-03-17 |
2006-04-18 |
Natural Asa |
Conjugated linoleic acid compositions
|
|
US7776353B1
(en)
|
1998-03-17 |
2010-08-17 |
Aker Biomarine Asa |
Conjugated linoleic acid compositions
|
|
US6015833A
(en)
|
1998-03-17 |
2000-01-18 |
Conlinco., Inc. |
Conjugated linoleic acid compositions
|
|
US6177580B1
(en)
|
1998-04-21 |
2001-01-23 |
Henkel Kommanditgesellschaft Auf Aktien |
Conjugated linolenic acid-based synthetic triglycerides
|
|
US6060514A
(en)
|
1998-05-04 |
2000-05-09 |
Conlin Co., Inc. |
Isomer enriched conjugated linoleic acid compositions
|
|
US6214372B1
(en)
|
1998-05-04 |
2001-04-10 |
Con Lin Co., Inc. |
Method of using isomer enriched conjugated linoleic acid compositions
|
|
US6696584B2
(en)
|
1998-05-04 |
2004-02-24 |
Natural Asa |
Isomer enriched conjugated linoleic acid compositions
|
|
US7101914B2
(en)
|
1998-05-04 |
2006-09-05 |
Natural Asa |
Isomer enriched conjugated linoleic acid compositions
|
|
US6777388B1
(en)
*
|
1998-08-21 |
2004-08-17 |
Clf Medical Technology Acceleration Program, Inc. |
Leptin-related peptides
|
|
US6132582A
(en)
|
1998-09-14 |
2000-10-17 |
The Perkin-Elmer Corporation |
Sample handling system for a multi-channel capillary electrophoresis device
|
|
GB9901809D0
(en)
*
|
1999-01-27 |
1999-03-17 |
Scarista Limited |
Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
|
|
IT1308613B1
(it)
|
1999-02-17 |
2002-01-09 |
Pharmacia & Upjohn Spa |
Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
|
|
US7235583B1
(en)
*
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
|
US6245800B1
(en)
*
|
1999-06-08 |
2001-06-12 |
Sigma-Tau |
Method of preventing or treating statin-induced toxic effects using L-carnitine or an alkanoyl L-carnitine
|
|
GB9918028D0
(en)
*
|
1999-07-30 |
1999-09-29 |
Unilever Plc |
Skin care composition
|
|
GB9927629D0
(en)
|
1999-11-24 |
2000-01-19 |
Croda Int Plc |
Compounds
|
|
AU5144901A
(en)
|
2000-04-06 |
2001-10-23 |
Conlinco Inc |
Conjugated linoleic acid compositions
|
|
AU5543101A
(en)
|
2000-04-18 |
2001-10-30 |
Natural As |
Conjugated linoleic acid powder
|
|
US6380409B1
(en)
|
2000-04-24 |
2002-04-30 |
Conlin Co., Inc. |
Methods for preparing CLA isomers
|
|
US6927239B1
(en)
*
|
2000-08-02 |
2005-08-09 |
Pharmanutrients |
Methods and compositions for the attenuation and/or prevention of stress/catabolic responses
|
|
US6506412B2
(en)
*
|
2000-11-29 |
2003-01-14 |
Sciencebased Health |
Treatment of dry eye syndrome
|
|
ITMI20010129A1
(it)
|
2001-01-25 |
2002-07-25 |
Pharmacia & Upjohn Spa |
Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
|
|
RU2203064C2
(ru)
*
|
2001-03-11 |
2003-04-27 |
Каменев Виктор Федорович |
Способ лечения аспириновой бронхиальной астмы
|
|
AU2002303164A1
(en)
*
|
2001-03-23 |
2002-10-08 |
Protarga, Inc. |
Fatty amine drug conjugates
|
|
EP1423107B1
(en)
*
|
2001-03-23 |
2012-05-09 |
Luitpold Pharmaceuticals, Inc. |
Fatty alcohol drug conjugates
|
|
EP1380293A4
(en)
*
|
2001-03-30 |
2009-03-18 |
Nisshin Oillio Group Ltd |
MEANS TO IMPROVE BONE MATERIAL CHANGE
|
|
CA2372450A1
(en)
*
|
2001-05-10 |
2001-09-19 |
Pharmaceutical Partners Of Canada Inc. |
Liquid injectable formulation of disodium pamidronate
|
|
US6838074B2
(en)
|
2001-08-08 |
2005-01-04 |
Bristol-Myers Squibb Company |
Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
|
|
US8460693B2
(en)
*
|
2001-11-08 |
2013-06-11 |
Atrium Medical Corporation |
Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent
|
|
ITMI20012384A1
(it)
*
|
2001-11-12 |
2003-05-12 |
Quatex Nv |
Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
|
|
US6677470B2
(en)
|
2001-11-20 |
2004-01-13 |
Natural Asa |
Functional acylglycerides
|
|
RU2223765C1
(ru)
*
|
2002-07-24 |
2004-02-20 |
Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" |
Противовоспалительный и антиаллергический состав
|
|
US6743931B2
(en)
|
2002-09-24 |
2004-06-01 |
Natural Asa |
Conjugated linoleic acid compositions
|
|
EP2283837A3
(en)
*
|
2002-09-27 |
2011-04-20 |
Martek Biosciences Corporation |
Docosahexaenoic acid for treating subclinical inflammation
|
|
US7074418B2
(en)
*
|
2002-11-18 |
2006-07-11 |
Changaris David G |
Conjugated fatty acid based emulsion and methods for preparing and using same
|
|
CN1816287A
(zh)
*
|
2003-01-31 |
2006-08-09 |
宝洁公司 |
改善哺乳动物角质组织外观的方法
|
|
US20050123500A1
(en)
*
|
2003-01-31 |
2005-06-09 |
The Procter & Gamble Company |
Means for improving the appearance of mammalian hair and nails
|
|
WO2004091603A1
(fr)
*
|
2003-04-07 |
2004-10-28 |
Clinigenetics |
Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires
|
|
US7091369B2
(en)
*
|
2003-07-15 |
2006-08-15 |
Board Of Trustees Operating Michigan State University |
Synthesis of polyconjugated fatty acids
|
|
US7041286B2
(en)
*
|
2003-07-23 |
2006-05-09 |
Nerenberg Arnold P |
Composition for mitigating a pernicious thrombotic event
|
|
US20050075398A1
(en)
*
|
2003-08-05 |
2005-04-07 |
Bazan Nicolas G. |
Neuroprotectin D1 protects against cellular apoptosis, stroke damage, alzheimer's disease and retinal diseases
|
|
CA2436650A1
(en)
*
|
2003-08-06 |
2005-02-06 |
Naturia Inc. |
Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
|
|
US20050074443A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Treadwell Benjamin V. |
Methods of attenuating autoimmune disease and compositions useful therefor
|
|
US20050154059A1
(en)
*
|
2004-01-13 |
2005-07-14 |
Cook Mark E. |
Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
|
|
EP1811933B1
(en)
|
2004-09-28 |
2016-03-23 |
Atrium Medical Corporation |
Barrier layer
|
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
US8312836B2
(en)
|
2004-09-28 |
2012-11-20 |
Atrium Medical Corporation |
Method and apparatus for application of a fresh coating on a medical device
|
|
US8367099B2
(en)
|
2004-09-28 |
2013-02-05 |
Atrium Medical Corporation |
Perforated fatty acid films
|
|
WO2006036970A2
(en)
*
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Method of thickening a coating using a drug
|
|
WO2006036982A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Drug delivery coating for use with a stent
|
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
CN101098690A
(zh)
*
|
2004-12-06 |
2008-01-02 |
瑞莱恩特医药品有限公司 |
用于血脂治疗的ω-3脂肪酸和脂血异常剂
|
|
MX2007006775A
(es)
*
|
2004-12-06 |
2008-02-25 |
Reliant Pharmaceuticals Inc |
Composiciones estables de fenofibrato con esteres de acido graso.
|
|
KR101356335B1
(ko)
*
|
2004-12-06 |
2014-02-06 |
릴라이언트 파마슈티컬스 인코퍼레이티드 |
지질 치료를 위한 오메가-3 지방산 및 이상지질혈증 제제
|
|
US20060135610A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bortz Jonathan D |
Cardiovascular compositions
|
|
EA200701913A1
(ru)
*
|
2005-03-08 |
2008-08-29 |
Релайэнт Фармасьютикалз, Инк. |
Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом
|
|
US20060229366A1
(en)
*
|
2005-04-07 |
2006-10-12 |
Lifschitz Carlos H |
Method for preventing or treating respiratory infections in infants
|
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
|
WO2007047781A2
(en)
|
2005-10-15 |
2007-04-26 |
Atrium Medical Corporation |
Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
|
|
CA2630600A1
(en)
*
|
2005-11-22 |
2007-05-31 |
University Of Rochester |
Mitochondria-targeted antioxidant prodrugs and methods of use
|
|
US8470861B2
(en)
|
2005-11-22 |
2013-06-25 |
University Of Rochester |
Mitochondria-targeted antioxidant prodrugs and methods of use
|
|
ES2277557B1
(es)
|
2005-12-21 |
2008-07-01 |
Proyecto Empresarial Brudy, S.L. |
Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
|
|
EP1962825B1
(en)
|
2005-12-21 |
2014-04-02 |
Brudy Technology, S.L. |
Use of dha for treating a pathology associated with cellular oxidative damage
|
|
WO2007081773A2
(en)
*
|
2006-01-05 |
2007-07-19 |
Reliant Pharmaceuticals, Inc |
Treatment of fatty liver
|
|
US8247460B2
(en)
*
|
2006-02-03 |
2012-08-21 |
Giulio Cossu |
Method of treatment for muscular dystrophy
|
|
TWI389683B
(zh)
*
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
|
US20070203276A1
(en)
*
|
2006-02-10 |
2007-08-30 |
Gyorgyi Fenyvesi |
Plasticizers comprising biologically-based mono and di esters
|
|
US20070275139A1
(en)
*
|
2006-02-10 |
2007-11-29 |
Melissa Joerger |
Food compositions comprising renewably-based, biodegradable1,3-propanediol
|
|
JP2009532506A
(ja)
*
|
2006-02-10 |
2009-09-10 |
デユポン・テイト・アンド・ライル・バイオ・プロダクツ・カンパニー・エルエルシー |
生物学的ベースの１，３−プロパンジオールのモノエステルおよびジエステルを含む組成物
|
|
WO2007103557A2
(en)
|
2006-03-09 |
2007-09-13 |
Reliant Pharmaceuticals, Inc. |
Coating capsules with active pharmaceutical ingredients
|
|
JP5099808B2
(ja)
*
|
2006-05-29 |
2012-12-19 |
独立行政法人農業・食品産業技術総合研究機構 |
脂質代謝改善用組成物
|
|
EP2083875B1
(en)
|
2006-11-06 |
2013-03-27 |
Atrium Medical Corporation |
Coated surgical mesh
|
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
|
WO2008061187A1
(en)
*
|
2006-11-15 |
2008-05-22 |
Dupont Tate & Lyle Bio Products Company, Llc |
Preservative compositions comprising renewably-based, biodegradable 1,3-propanediol
|
|
US20090029944A1
(en)
*
|
2007-06-19 |
2009-01-29 |
Skinner Keith K |
Methods for adding fatty acids to agents in aqueous solution to improve bioavailability
|
|
DK2315740T3
(en)
|
2008-07-08 |
2018-01-08 |
Catabasis Pharmaceuticals Inc |
Fatty Acid Acetylated Salicylates and Their Uses
|
|
US9085527B2
(en)
|
2008-07-08 |
2015-07-21 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid acylated salicylates and their uses
|
|
US20120034156A1
(en)
*
|
2010-08-03 |
2012-02-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Artificial cells
|
|
PT2334295T
(pt)
|
2008-09-02 |
2017-09-15 |
Amarin Pharmaceuticals Ie Ltd |
Composição farmacêutica compreendendo ácido eicosapentanoico e ácido nicotínico e métodos de utilização dos mesmos
|
|
US20100062057A1
(en)
*
|
2008-09-10 |
2010-03-11 |
Pronova BioPharma Norge AS. |
Formulation
|
|
FR2940281B1
(fr)
|
2008-12-22 |
2011-04-01 |
Fabre Pierre Dermo Cosmetique |
Ester de diol et d'acide gras polyinsature comme agent anti-acne
|
|
US8293727B2
(en)
|
2009-02-10 |
2012-10-23 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
|
EP2405903B1
(en)
|
2009-03-09 |
2024-04-10 |
Basf As |
Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
|
|
CN107233337A
(zh)
|
2009-04-29 |
2017-10-10 |
阿马里纳药物爱尔兰有限公司 |
含有epa和心血管剂的药物组合物以及使用其的方法
|
|
SI2424356T1
(en)
|
2009-04-29 |
2018-01-31 |
Armarin Pharmaceuticals Ireland Limited |
A stable pharmaceutical composition and procedures for its use
|
|
WO2010147994A1
(en)
|
2009-06-15 |
2010-12-23 |
Amarin Pharma, Inc. |
Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
|
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
|
US8304551B2
(en)
|
2009-09-01 |
2012-11-06 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid niacin conjugates and their uses
|
|
USRE46608E1
(en)
|
2009-09-01 |
2017-11-14 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid niacin conjugates and their uses
|
|
MX2012003555A
(es)
|
2009-09-23 |
2012-07-03 |
Amarin Corp Plc |
Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
|
|
WO2011044138A1
(en)
|
2009-10-05 |
2011-04-14 |
Catabasis Pharmaceuticals, Inc. |
Lipoic acid acylated salicylate derivatives and their uses
|
|
US9370493B2
(en)
|
2009-10-23 |
2016-06-21 |
Pronova Biopharma Norge As |
Coated capsules and tablets of a fatty acid oil mixture
|
|
US20110212958A1
(en)
*
|
2010-02-26 |
2011-09-01 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid raloxifene derivatives and their uses
|
|
EP2542060B1
(en)
*
|
2010-03-04 |
2019-10-02 |
Amarin Pharmaceuticals Ireland Limited |
Compositions for treating and/or preventing cardiovascular disease
|
|
WO2011109681A1
(en)
|
2010-03-05 |
2011-09-09 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid cox inhibitor derivatives and their uses
|
|
WO2011143587A1
(en)
|
2010-05-13 |
2011-11-17 |
Nitromega Corp. |
Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline
|
|
EP2593141B1
(en)
|
2010-07-16 |
2018-07-04 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
|
US11712429B2
(en)
|
2010-11-29 |
2023-08-01 |
Amarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
|
NZ727980A
(en)
|
2010-11-29 |
2018-08-31 |
Amarin Pharmaceuticals Ie Ltd |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
|
US8951514B2
(en)
|
2011-02-16 |
2015-02-10 |
Pivotal Therapeutics Inc. |
Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
|
|
US8715648B2
(en)
|
2011-02-16 |
2014-05-06 |
Pivotal Therapeutics Inc. |
Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
|
|
US9119826B2
(en)
|
2011-02-16 |
2015-09-01 |
Pivotal Therapeutics, Inc. |
Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
|
|
US8952000B2
(en)
|
2011-02-16 |
2015-02-10 |
Pivotal Therapeutics Inc. |
Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
|
|
CA2830975C
(en)
|
2011-04-13 |
2016-06-21 |
Elc Management Llc |
Mild anionic surfactants suitable for personal care compositions
|
|
CN103476914A
(zh)
|
2011-04-13 |
2013-12-25 |
Elc管理公司 |
用于个人护理组合物的调节剂
|
|
US8809560B2
(en)
|
2011-05-17 |
2014-08-19 |
Board Of Trustees Of The University Of Arkansas |
Trans-, trans-conjugated linoleic acid compositions and use thereof
|
|
EP2775837A4
(en)
|
2011-11-07 |
2015-10-28 |
Amarin Pharmaceuticals Ie Ltd |
METHODS OF TREATING HYPERTRIGLYCERIDEMIA
|
|
US11291643B2
(en)
|
2011-11-07 |
2022-04-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
|
EP2776544A1
(en)
|
2011-11-09 |
2014-09-17 |
Evonik Membrane Extraction Technology Limited |
Membrane-based processes for reducing at least one impurity and making a concentrate comprising at least one natural component from a non-marine fatty acid oil mixture, and compositions resulting thereof
|
|
WO2013072767A1
(en)
|
2011-11-18 |
2013-05-23 |
Pronova Biopharma Norge As |
Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
ES2885523T3
(es)
|
2011-11-23 |
2021-12-14 |
Therapeuticsmd Inc |
Formulaciones y terapias de reposición hormonal de combinación naturales
|
|
WO2013093630A2
(en)
|
2011-12-22 |
2013-06-27 |
Pronova Biopharma Norge As |
Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
|
|
ES2891473T3
(es)
|
2012-01-06 |
2022-01-28 |
Amarin Pharmaceuticals Ie Ltd |
Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
|
|
US9295662B2
(en)
|
2012-03-07 |
2016-03-29 |
Children's Medical Center Corporation |
Methods for enhancing, improving, or increasing fertility or reproductive function
|
|
US20150079164A1
(en)
|
2012-04-04 |
2015-03-19 |
Pronova Biopharma Norge As |
Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
|
|
US9585896B2
(en)
|
2012-04-04 |
2017-03-07 |
Pronova Biopharma Norge As |
Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof
|
|
EP2882427A2
(en)
*
|
2012-05-08 |
2015-06-17 |
Cellixbio Private Limited |
Compositions and methods for the treatment of neurological disorders
|
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
|
EP2861227A4
(en)
|
2012-06-17 |
2016-01-27 |
Matinas Biopharma Inc |
OMEGA-3 PENTAIC ACID COMPOSITIONS AND METHODS OF USE
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
EP3815684B1
(en)
|
2012-06-29 |
2024-09-04 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
|
|
WO2014006529A2
(en)
*
|
2012-07-03 |
2014-01-09 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
|
JP2014050781A
(ja)
*
|
2012-09-06 |
2014-03-20 |
Shiko Actec Kk |
油煙含有排気用脱臭フィルタ
|
|
WO2014074552A2
(en)
|
2012-11-06 |
2014-05-15 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
|
|
US9062276B2
(en)
|
2012-12-03 |
2015-06-23 |
Board Of Trustees Of The University Of Arkansas |
Conjugated linoleic acid rich vegetable oil production from linoleic rich oils by heterogeneous catalysis
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US9814733B2
(en)
|
2012-12-31 |
2017-11-14 |
A,arin Pharmaceuticals Ireland Limited |
Compositions comprising EPA and obeticholic acid and methods of use thereof
|
|
US20140187633A1
(en)
|
2012-12-31 |
2014-07-03 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
|
|
US9452151B2
(en)
|
2013-02-06 |
2016-09-27 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing apolipoprotein C-III
|
|
US9624492B2
(en)
|
2013-02-13 |
2017-04-18 |
Amarin Pharmaceuticals Ireland Limited |
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
|
|
US9662307B2
(en)
|
2013-02-19 |
2017-05-30 |
The Regents Of The University Of Colorado |
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
|
|
US9283201B2
(en)
|
2013-03-14 |
2016-03-15 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for treating or preventing obesity in a subject in need thereof
|
|
US20140271841A1
(en)
|
2013-03-15 |
2014-09-18 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
|
|
US20150182546A1
(en)
*
|
2013-03-15 |
2015-07-02 |
Mitochondrial Concepts Llc |
Therapeutic agent for enhancing mitochondrial function
|
|
US10966968B2
(en)
|
2013-06-06 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
|
|
WO2015011724A2
(en)
|
2013-07-22 |
2015-01-29 |
Kms Health Center Pvt Ltd |
A novel omega -3 fatty acid composition with a plant extract
|
|
CN103417507B
(zh)
*
|
2013-08-23 |
2015-12-02 |
王显著 |
布地奈德药物组合物
|
|
US20150065572A1
(en)
|
2013-09-04 |
2015-03-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing prostate cancer
|
|
US9585859B2
(en)
|
2013-10-10 |
2017-03-07 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
|
|
PT3057934T
(pt)
|
2013-10-18 |
2019-06-28 |
Blanchette Rockefeller Neurosciences Inst |
Ésteres halogenados de ácidos gordos insaturados ciclopropanados para uso no tratamento de doenças neurodegenerativas
|
|
US10130603B2
(en)
|
2013-11-05 |
2018-11-20 |
Colgate-Palmolive Company |
Methods and compositions for improving kidney function
|
|
MX2016014281A
(es)
|
2014-05-22 |
2017-02-22 |
Therapeuticsmd Inc |
Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
|
|
US10561631B2
(en)
|
2014-06-11 |
2020-02-18 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing RLP-C
|
|
WO2015195662A1
(en)
|
2014-06-16 |
2015-12-23 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
|
|
US10208014B2
(en)
*
|
2014-11-05 |
2019-02-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological disorders
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
US10669504B2
(en)
|
2015-07-28 |
2020-06-02 |
The Lubrizol Corporation |
Seal swell agents for lubrication compositions
|
|
US9968531B2
(en)
|
2015-08-05 |
2018-05-15 |
Dupont Tate & Lyle Bio Products Company, Llc |
Deodorants containing 1,3-propanediol
|
|
KR101835860B1
(ko)
|
2015-10-30 |
2018-03-09 |
순천향대학교 산학협력단 |
난소암 또는 경계성 난소종양의 예방 또는 치료용 조성물 및 진단용 마커 조성물
|
|
US10406130B2
(en)
|
2016-03-15 |
2019-09-10 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
|
WO2017222996A1
(en)
|
2016-06-20 |
2017-12-28 |
The California Institute For Biomedical Research |
Antimalarial compositions and uses thereof
|
|
FR3053252B1
(fr)
*
|
2016-06-29 |
2020-04-24 |
Laboratoires Carilene |
Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies
|
|
WO2018213663A1
(en)
|
2017-05-19 |
2018-11-22 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject having reduced kidney function
|
|
US10052300B1
(en)
*
|
2017-10-19 |
2018-08-21 |
David G. Changaris |
Methods and composition for suppression of deep seated fungal growth on skin
|
|
US11058661B2
(en)
|
2018-03-02 |
2021-07-13 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
|
|
KR102076314B1
(ko)
*
|
2018-07-16 |
2020-02-11 |
(주) 에프엔지리서치 |
녹용에서 분리한 신규 화합물 및 이의 약학적 용도
|
|
ES2983568T3
(es)
|
2018-09-24 |
2024-10-23 |
Amarin Pharmaceuticals Ie Ltd |
Métodos para reducir el riesgo de eventos cardiovasculares en un sujeto
|
|
EP4058141A4
(en)
|
2019-11-12 |
2023-11-22 |
Amarin Pharmaceuticals Ireland Limited |
METHOD FOR REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT WITH Atrial fibrillation and/or atrial flutter
|
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
|
AU2022263358A1
(en)
|
2021-04-21 |
2023-11-30 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of heart failure
|
|
EP4306101A1
(en)
|
2022-07-14 |
2024-01-17 |
Gat Therapeutics S.L. |
Compositions comprising amarouciaxanthin a esters and uses thereof
|